Solanesol

Solanesol

SCHEMBL6317060

CC(C)=CCC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CC/C(C)=C/CO.CCO

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Solanesol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.91
MAPT P10636 2/20 0.91
MEN1 O00255 2/20 0.91
CYP3A4 P08684 2/20 0.91
ALOX15 P16050 2/20 0.91
ALDH1A1 P00352 1/20 0.91
UGT1A1 P22309 1/20 0.91
SQLE Q14534 7/20 0.65
KDM4E B2RXH2 1/20 0.55
ICMT O60725 1/20 0.53
FNTA P49354 1/20 0.50
FNTB P49356 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Farnesol SCHEMBL11215938 1.00 KMT2A (0.91) KMT2AMAPTMEN1CYP3A4ALOX15
Farnesol SCHEMBL1549561 1.00 KMT2A (0.91) KMT2AMAPTMEN1CYP3A4ALOX15
Nerol SCHEMBL5372628 0.98 KMT2A (0.91) KMT2AMAPTMEN1CYP3A4ALOX15
Geraniol SCHEMBL1665820 0.98 KMT2A (0.91) KMT2AMAPTMEN1CYP3A4ALOX15
Geraniol SCHEMBL8124286 0.98 KMT2A (0.91) KMT2AMAPTMEN1CYP3A4ALOX15
Geraniol SCHEMBL668456 0.98 KMT2A (0.91) KMT2AMAPTMEN1CYP3A4ALOX15
Geranylgeraniol SCHEMBL23814969 0.95 KMT2A (1.00) KMT2AMAPTMEN1CYP3A4ALOX15
Farnesol SCHEMBL7546574 0.95 KMT2A (1.00) KMT2AMAPTMEN1CYP3A4ALOX15
SCHEMBL4717874 0.95 KMT2A (1.00) KMT2AMAPTMEN1CYP3A4ALOX15
SCHEMBL7944378 0.95 KMT2A (1.00) KMT2AMAPTMEN1CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328654-A4 A PRACTICAL, COST-EFFECTIVE SYNTHESIS OF COQ10 UNIV CALIFORNIA (US) 2005-10-26 EP disclosed
US-20050137410-A1 Practical, cost-effective synthesis of CoQ10 ZYMES, INC. (US) 2005-06-23 US disclosed
US-6852895-B2 Oxidation of a phenol compound ZYMES, INC. (US) 2005-02-08 US disclosed
EP-1328654-A1 A PRACTICAL, COST-EFFECTIVE SYNTHESIS OF COQ10 The Regents of the University of California (US) 2003-07-23 EP disclosed
US-20030073869-A1 Practical, cost-effective synthesis of CoQ10 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2003-04-17 US disclosed
US-6545184-B1 Electron transfer THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2003-04-08 US disclosed
WO-2002014530-A1 A PRACTICAL, COST-EFFECTIVE SYNTHESIS OF COQ10 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2002-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137410-A1 Practical, cost-effective synthesis of CoQ10 NDUFA10, NDUFB10, NDUFS6 KMT2A 2695/4885MAPT 3675/4885MEN1 1803/4885
US-20030073869-A1 Practical, cost-effective synthesis of CoQ10 NDUFA10, NDUFB10, NDUFS6 KMT2A 2695/4885MAPT 3675/4885MEN1 1803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.